Precigen Inc (PGEN)

R&D to Revenue

13.25%

Quarterly · Period ending:

PGEN logo

PGEN R&D to Revenue

Latest reported13.25%
PGEN Quarterly R&D/Revenue (1172.99% → 13.25%)
High-resolution chart · PNG

PGEN r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Precigen Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
13.2453%
22.8798%
146.1555%
412.6968%
1,342.0561%
757.569%
988.0672%
1,193.0745%
2,188.7029%
1,337.9343%
1,058.1433%
839.9565%
671.9864%
657.1043%
612.1951%
75.4814%
410.6493%
214.0577%
330.5646%
373.0573%
345.5832%
295.1092%
-18.6676%
43.1328%
31.1399%
37.9617%
33.7282%
136.6142%
95.9206%
141.6842%
649.5635%
138.329%
92.8747%
85.001%
50.0389%
79.2594%
62.4823%
63.5942%
63.0842%
59.2732%
54.0466%
59.5239%
63.1283%
40.4707%
45.4011%
234.2964%
56.7349%
70.0618%
122.8387%
153.947%
175.9905%
175.4932%
200.5899%
289.2857%
198.3323%
491.0769%
647.1387%
1,172.9913%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.